210 related articles for article (PubMed ID: 15770999)
1. Parkinson's disease: from causes to mechanisms.
Corti O; Hampe C; Darios F; Ibanez P; Ruberg M; Brice A
C R Biol; 2005 Feb; 328(2):131-42. PubMed ID: 15770999
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.
Barzilai A; Melamed E
Trends Mol Med; 2003 Mar; 9(3):126-32. PubMed ID: 12657434
[TBL] [Abstract][Full Text] [Related]
3. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
4. New movement in Parkinson's.
Lozano AM; Kalia SK
Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
[No Abstract] [Full Text] [Related]
5. Molecular pathophysiology of Parkinson's disease.
Moore DJ; West AB; Dawson VL; Dawson TM
Annu Rev Neurosci; 2005; 28():57-87. PubMed ID: 16022590
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Parkinsonism: a review.
Vaughan JR; Davis MB; Wood NW
Ann Hum Genet; 2001 Mar; 65(Pt 2):111-26. PubMed ID: 11427172
[TBL] [Abstract][Full Text] [Related]
8. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch EC
Ann Neurol; 1995 Feb; 37(2):265-72. PubMed ID: 7847868
[TBL] [Abstract][Full Text] [Related]
9. Recessive Parkinson's disease.
Kubo S; Hattori N; Mizuno Y
Mov Disord; 2006 Jul; 21(7):885-93. PubMed ID: 16615060
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
11. [Heterogeneity of Parkinson's disease].
Vidailhet M
Bull Acad Natl Med; 2003; 187(2):259-75; discussion 275-6. PubMed ID: 14556440
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
Lim KL; Lim TM
IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
[TBL] [Abstract][Full Text] [Related]
13. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
Di Monte DA
Lancet Neurol; 2003 Sep; 2(9):531-8. PubMed ID: 12941575
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
15. Are ubiquitination pathways central to Parkinson's disease?
Giasson BI; Lee VM
Cell; 2003 Jul; 114(1):1-8. PubMed ID: 12859888
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O
Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
[No Abstract] [Full Text] [Related]
17. Nosology of Parkinson's disease: looking for the way out of a quagmire.
Forman MS; Lee VM; Trojanowski JQ
Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
[TBL] [Abstract][Full Text] [Related]
18. [Genetics and environmental factors of Parkinson disease].
Broussolle E; Thobois S
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic approaches to Parkinson's disease pathogenesis.
Betarbet R; Sherer TB; Di Monte DA; Greenamyre JT
Brain Pathol; 2002 Oct; 12(4):499-510. PubMed ID: 12408237
[TBL] [Abstract][Full Text] [Related]
20. New aspects of genetic contributions to Parkinson's disease.
Hofer A; Gasser T
J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
